Evidence map›Paper›PMID 27037280›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2016

Chelidonic acid evokes antidepressant-like effect through the up-regulation of BDNF in forced swimming test.

Hyun-Ja Jeong, Shi-Young Yang, Hee-Yun Kim, Na-Rae Kim, Jae-Bum Jang, Hyung-Min Kim

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Chelidonic acid amelioratesFrontiers in immunology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Therapeutic of Candesartan and Music Therapy in Diabetic Retinopathy with Depression in Rats.Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Hyun-Ja JeongDepartment of Food Technology and NanoBio Tronics, Hoseo University, Asan 336-795, Republic of Korea.
Shi-Young YangProfessional Graduate School of Flexible and Printable Electronics, Center for R&D Strategy, Chonbuk National University, Jeonju 561-756, Republic of Korea.
Hee-Yun KimDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.
Na-Rae KimDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.
Jae-Bum JangRegional Innovation Center and Inflammatory Disease Research Center, Hoseo University, Asan 336-795, Republic of Korea *The first two authors contributed equally to this work.
Hyung-Min KimDepartment of Pharmacology, College of Korean Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea hmkim@khu.ac.kr.
Kyung Hee University · KRHoseo University · KRJeonbuk National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Depression is usually accompanied by neuro-inflammatory reactions. Chelidonic acid, in particular, has shown anti-inflammatory effects. The objective of this study was to evaluate the anti-depressant effects of chelidonic acid and to discuss the potential mechanisms of a forced swimming test. Chelidonic acid was administered orally once a day for 14 days. On the 14th day, chelidonic acid resulted in a significant decrease in immobility time during the forced swimming test without alteration of locomotor activity, in an open field test. Chelidonic acid also increased the number of nissl bodies in the hippocampus. Brain-derived neurotrophic factor expression and extracellular signal-regulated protein kinase phosphorylation in the hippocampus were up-regulated by the administration of chelidonic acid. Chelidonic acid administration significantly increased the mRNA expression of hippocampal estrogen receptor-β. The levels of hippocampal interleukin (IL)-1β, IL-6, and tumor necrosis factor-α were effectively attenuated by the administration of chelidonic acid. In addition, chelidonic acid significantly increased the levels of 5-hydroxytryptamine (serotonin), dopamine, and norepinephrine compared with those levels for the mice that were administered distilled water in the hippocampus. These results suggest that chelidonic acid might serve as a new therapeutic strategy for the regulation of depression associated with inflammation.

Indexed as

AnimalsBrain-Derived Neurotrophic FactorDopamineHippocampusInterleukin-1betaInterleukin-6MaleMiceMice, Inbred ICRNeurotransmitter AgentsNissl BodiesNorepinephrinePyransSerotoninSwimmingTumor Necrosis Factor-alphaBrain-Derived Neurotrophic Factorchelidonic acidDopamineInterleukin-1betaInterleukin-6Neurotransmitter AgentsNorepinephrinePyransSerotoninTumor Necrosis Factor-alphabrain-derived neurotrophic factorchelidonic acidDepressionestrogen receptor-βserotonin

Identifiers

PMID27037280
PMCPMC4994898
OpenAlexW2326394357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.